Onychomycosis is a pervasive, disfiguring, and often painful infection of the nail, surface of the nail bed, and/or nail matrix caused by fungi that are ubiquitous in the environment
Over 35 million patients in the US suffer from this type of infection, including approximately 1 in 3 diabetic patients. Research demonstrates an increased risk of other foot disorders and amputations in diabetic patients with onychomycosis.
There are no current treatments that effectively treat this type of infection.
Our patented TherawaveTM 100 technology delivers a safe and effective High Frequency Energy (HFE) precisely to the infected nail plate and surface nail bed to eliminate the fungal infection while sparing surrounding tissue.
*The Therawave100 is under development and is not available for sale.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Milwaukee, Wi, Us
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://www.accuremedical.com
- Keywords
- Medical device, Dermatology, Podiatry, Toe fungus.
- HQ
- Milwaukee, WI
Biacure Therapies Inc. Questions
Biacure Therapies Inc.'s website is http://www.accuremedical.com
Biacure Therapies Inc.'s LinkedIn profile is https://www.linkedin.com/company/biacure
Biacure Therapies Inc. has
6 employees.
View email and phone details for 6
employees at Biacure Therapies Inc..
Biacure Therapies Inc.'s industry is
Medical Equipment Manufacturing
Biacure Therapies Inc.'s top competitors are
Polco,
Verdego Aero,
Acer Biomedicals,
G. M. Medicare,
Elephas,
Acer Biomedicals Llp,
Accure Medical Pvt Ltd.,
Microelastic Ultrasound Systems,
Meldermatix,
Truelastin, Inc..
Biacure Therapies Inc.'s categories are Medical Equipment Manufacturing
Biacure Therapies Inc.'s founding year is 2023
